Black Diamond Therapeutics: Fang Ni, chief business officer
Oncology medicine specialists Black Diamond Therapeutics have appointed Fang Ni as the company’s chief business officer. His past experience includes serving as principal and investment team member at Versant Ventures, and as global business development and licensing director with Roche’s Partnering organization.
“Fang’s proven track record in business development and corporate strategy, including his work as Black Diamond’s interim chief business officer, gives us confidence that he has the optimal expertise to expand and execute our strategic and business development initiatives,” said David Epstein, president and CEO of Black Diamond Therapeutics. “Fang’s leadership of this critical function will be key as we advance our pipeline of clinical and discovery programs derived from the MAP platform.”
